January 13, 2021 – BIOTECanada is pleased to announce the launch of Bio+ech Connec+, a unique forum for early-stage Canadian biotech companies to connect directly with the business development and investment leaders of multinational pharma/biotech companies.
The first Bio+ech Connec+ will take place on February 9 featuring Gilead Sciences Canada Inc.
This virtual forum will include a plenary session led by senior Gilead representatives who will provide an overview of the company, its R&D priorities including its pipeline and corresponding investment priorities for the period ahead. Gilead representatives will then engage in a question and answer session Following the plenary and Q&A session a select group of early stage companies will be provided an opportunity to connect bilaterally with the Gilead representatives.
Bio+ech Connec+ with Gilead will be held onTuesday, February 9, 1:00 – 4:00 pm ET
All BIOTECanada members are eligible to participate in the opening plenary/Q&A session.
If you would like to participate in the one-on-one meeting session following the plenary, please apply by Wednesday, January 20th. You will be notified if you have secured a meeting by Monday, February 1.